Hayley T DO, PA
Physician Assistant · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 3
Offices
3 locations · One Medical Group Inc · 330 clinicians in this group
Looking this up.
Hospitals listed: Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Hayley T DO’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Drugs they prescribed that Part D paid
$220,318
Pharmacies billed $220,318 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (34 of 2,099) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
1,866 generic and fewer than 11 brand-name prescriptions · $220,318 in drug cost · 168 antibiotic prescriptions to 109 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 20 | $32,660 | $1,633 |
| Trelegy Ellipta | 31 | $27,676 | $893 |
| Eliquis | 28 | $27,167 | $970 |
| Estradiol | 23 | $2,183 | $95 |
| Fluticasone-Salmeterol | 17 | $2,097 | $123 |
See all 60 drugs
| Ozempic | 20 | $32,660 | $1,633 |
| Trelegy Ellipta | 31 | $27,676 | $893 |
| Eliquis | 28 | $27,167 | $970 |
| Estradiol | 23 | $2,183 | $95 |
| Fluticasone-Salmeterol | 17 | $2,097 | $123 |
| Memantine | 14 | $2,019 | $144 |
| Paxlovid | 14 | $1,429 | $102 |
| Omeprazole | 61 | $1,314 | $22 |
| Donepezil | 17 | $1,298 | $76 |
| Fluticasone Propionate | 107 | $1,285 | $12 |
| Simvastatin | 33 | $1,020 | $31 |
| Atorvastatin | 105 | $1,017 | $10 |
| Levothyroxine | 58 | $1,010 | $17 |
| Albuterol Sulfate Hfa | 27 | $762 | $28 |
| Synthroid | 11 | $761 | $69 |
| Hydroxyzine | 36 | $760 | $21 |
| Gabapentin | 64 | $755 | $12 |
| Lisinopril | 47 | $568 | $12 |
| Tamsulosin | 25 | $545 | $22 |
| Pantoprazole | 29 | $506 | $17 |
| Diclofenac | 22 | $473 | $21 |
| Ondansetron Odt | 27 | $464 | $17 |
| Losartan | 55 | $440 | $8 |
| Metoprolol | 38 | $397 | $10 |
| Duloxetine | 20 | $390 | $19 |
| Rosuvastatin | 31 | $382 | $12 |
| Montelukast | 23 | $361 | $16 |
| Nitrofurantoin Mono-Macro | 41 | $357 | $9 |
| Oxybutynin Chloride Er | 11 | $318 | $29 |
| Metformin Hcl Er | 14 | $304 | $22 |
| Nystatin | 18 | $302 | $17 |
| Hydrochlorothiazide | 31 | $281 | $9 |
| Alendronate | 20 | $251 | $13 |
| Famotidine | 15 | $227 | $15 |
| Allopurinol | 12 | $201 | $17 |
| Atenolol | 13 | $199 | $15 |
| Escitalopram | 11 | $190 | $17 |
| Furosemide | 25 | $183 | $7 |
| Hydrocodone-Acetaminophen | 11 | $182 | $17 |
| Amlodipine Besylate | 37 | $171 | $5 |
| Azithromycin | 50 | $171 | $3 |
| Trazodone | 19 | $166 | $9 |
| Metformin | 23 | $155 | $7 |
| Amoxicillin-Clavulanate Potass | 17 | $115 | $7 |
| Acyclovir | 11 | $113 | $10 |
| Ibuprofen | 16 | $104 | $7 |
| Lorazepam | 23 | $97 | $4 |
| Cyclobenzaprine | 15 | $94 | $6 |
| Buspirone | 11 | $91 | $8 |
| Fluoxetine | 14 | $84 | $6 |
| Celecoxib | 11 | $84 | $8 |
| Meclizine | 12 | $79 | $7 |
| Baclofen | 14 | $71 | $5 |
| Doxycycline Hyclate | 14 | $59 | $4 |
| Sertraline | 12 | $59 | $5 |
| Tramadol | 15 | $46 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $45 | $4 |
| Triamcinolone Acetonide | 14 | $44 | $3 |
| Alprazolam | 22 | $40 | $2 |
| Diazepam | 11 | $32 | $3 |
Year by year
| 2024 | 2,099 | 399 | 2% (34) | None | $220,318 |
| 2023 | 2,173 | 450 | 2% (33) | 11% | $197,968 |
| 2022 | 1,662 | 375 | 1% (24) | 12% | $138,222 |
| 2021 | 1,206 | 341 | 5% (62) | 17% | $122,026 |
| 2020 | 274 | 119 | None | 17% | $13,832 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 61 drugs
| Trelegy Ellipta | 28 | $26,534 | $948 |
| Eliquis | 17 | $18,316 | $1,077 |
| Januvia | 11 | $15,935 | $1,449 |
| Ozempic | 11 | $10,385 | $944 |
| Dayvigo | 12 | $4,774 | $398 |
| Estradiol | 20 | $1,591 | $80 |
| Atorvastatin | 104 | $1,580 | $15 |
| Memantine | 11 | $1,549 | $141 |
| Levothyroxine | 56 | $1,450 | $26 |
| Fluticasone Propionate | 101 | $1,331 | $13 |
| Duloxetine | 25 | $1,303 | $52 |
| Sertraline | 23 | $1,165 | $51 |
| Donepezil | 14 | $1,096 | $78 |
| Pantoprazole | 35 | $1,054 | $30 |
| Omeprazole | 44 | $1,017 | $23 |
| Losartan | 46 | $1,013 | $22 |
| Simvastatin | 29 | $992 | $34 |
| Montelukast | 29 | $958 | $33 |
| Quetiapine | 12 | $942 | $78 |
| Albuterol Sulfate Hfa | 46 | $916 | $20 |
| Gabapentin | 53 | $899 | $17 |
| Nitrofurantoin Mono-Macro | 59 | $887 | $15 |
| Ventolin Hfa | 14 | $871 | $62 |
| Nystatin | 31 | $856 | $28 |
| Metoprolol | 29 | $829 | $29 |
| Tamsulosin | 30 | $782 | $26 |
| Nitrofurantoin | 11 | $560 | $51 |
| Hydroxyzine | 17 | $466 | $27 |
| Lisinopril | 46 | $466 | $10 |
| Oxybutynin Chloride Er | 17 | $441 | $26 |
| Amlodipine Besylate | 37 | $389 | $11 |
| Metformin | 26 | $379 | $15 |
| Azithromycin | 61 | $353 | $6 |
| Benazepril | 13 | $332 | $26 |
| Allopurinol | 18 | $305 | $17 |
| Paxlovid (Eua) | 29 | $303 | $10 |
| Metformin Hcl Er | 20 | $286 | $14 |
| Triamcinolone Acetonide | 23 | $277 | $12 |
| Alendronate | 19 | $276 | $15 |
| Triamterene-Hydrochlorothiazid | 24 | $260 | $11 |
| Hydrocodone-Acetaminophen | 15 | $230 | $15 |
| Ibuprofen | 25 | $208 | $8 |
| Clotrimazole-Betamethasone | 12 | $197 | $16 |
| Sulfamethoxazole-Trimethoprim | 37 | $195 | $5 |
| Amoxicillin-Clavulanate Potass | 23 | $192 | $8 |
| Famotidine | 13 | $191 | $15 |
| Lorazepam | 19 | $184 | $10 |
| Metoprolol | 21 | $183 | $9 |
| Doxycycline Hyclate | 20 | $180 | $9 |
| Furosemide | 30 | $159 | $5 |
| Atenolol | 13 | $146 | $11 |
| Hydrochlorothiazide | 27 | $122 | $5 |
| Meloxicam | 11 | $114 | $10 |
| Cyclobenzaprine | 26 | $107 | $4 |
| Zolpidem | 14 | $103 | $7 |
| Spironolactone | 12 | $103 | $9 |
| Cephalexin | 13 | $99 | $8 |
| Alprazolam | 30 | $69 | $2 |
| Ciprofloxacin | 14 | $58 | $4 |
| Fluconazole | 11 | $55 | $5 |
| Diazepam | 16 | $47 | $3 |
2022: 51 drugs
| Trelegy Ellipta | 18 | $11,301 | $628 |
| Eliquis | 11 | $9,300 | $845 |
| Dayvigo | 22 | $7,890 | $359 |
| Anoro Ellipta | 15 | $7,337 | $489 |
| Myrbetriq | 11 | $4,591 | $417 |
| Albuterol Sulfate Hfa | 44 | $1,760 | $40 |
| Pregabalin | 12 | $1,456 | $121 |
| Estradiol | 15 | $1,200 | $80 |
| Atorvastatin | 66 | $961 | $15 |
| Levothyroxine | 41 | $859 | $21 |
| Metoprolol | 35 | $852 | $24 |
| Gabapentin | 37 | $811 | $22 |
| Nitrofurantoin Mono-Macro | 62 | $800 | $13 |
| Duloxetine | 21 | $765 | $36 |
| Fluticasone Propionate | 57 | $748 | $13 |
| Omeprazole | 32 | $707 | $22 |
| Montelukast | 34 | $619 | $18 |
| Losartan | 47 | $572 | $12 |
| Pantoprazole | 26 | $540 | $21 |
| Amlodipine Besylate | 32 | $407 | $13 |
| Lisinopril | 50 | $381 | $8 |
| Potassium Chloride | 12 | $325 | $27 |
| Simvastatin | 18 | $282 | $16 |
| Ketoconazole | 11 | $270 | $25 |
| Nystatin | 22 | $267 | $12 |
| Hydrocodone-Acetaminophen | 11 | $235 | $21 |
| Paxlovid (Eua) | 23 | $228 | $10 |
| Meloxicam | 17 | $224 | $13 |
| Azithromycin | 34 | $223 | $7 |
| Escitalopram | 15 | $223 | $15 |
| Trazodone | 14 | $214 | $15 |
| Ondansetron Odt | 13 | $210 | $16 |
| Allopurinol | 13 | $186 | $14 |
| Lorazepam | 19 | $182 | $10 |
| Metformin | 19 | $177 | $9 |
| Sulfamethoxazole-Trimethoprim | 49 | $174 | $4 |
| Metoprolol | 21 | $146 | $7 |
| Amoxicillin-Clavulanate Potass | 18 | $141 | $8 |
| Clotrimazole-Betamethasone | 13 | $139 | $11 |
| Hydrochlorothiazide | 35 | $131 | $4 |
| Triamcinolone Acetonide | 20 | $131 | $7 |
| Atenolol | 11 | $123 | $11 |
| Ciprofloxacin | 24 | $116 | $5 |
| Diazepam | 21 | $110 | $5 |
| Fluconazole | 15 | $102 | $7 |
| Sumatriptan | 12 | $101 | $8 |
| Alprazolam | 25 | $79 | $3 |
| Doxycycline Hyclate | 12 | $79 | $7 |
| Furosemide | 12 | $71 | $6 |
| Zolpidem | 13 | $58 | $4 |
| Cyclobenzaprine | 12 | $58 | $5 |
2021: 36 drugs
| Eliquis | 29 | $23,222 | $801 |
| Myrbetriq | 14 | $5,772 | $412 |
| Tolterodine Tartrate Er | 12 | $2,368 | $197 |
| Pregabalin | 14 | $1,152 | $82 |
| Gabapentin | 26 | $920 | $35 |
| Levothyroxine | 32 | $886 | $28 |
| Nitrofurantoin Mono-Macro | 56 | $883 | $16 |
| Atorvastatin | 47 | $806 | $17 |
| Hydrocodone-Acetaminophen | 35 | $783 | $22 |
| Sumatriptan | 12 | $624 | $52 |
| Lisinopril | 42 | $621 | $15 |
| Albuterol Sulfate Hfa | 13 | $524 | $40 |
| Metoprolol | 13 | $470 | $36 |
| Valacyclovir | 15 | $368 | $25 |
| Diclofenac | 13 | $354 | $27 |
| Mirtazapine | 12 | $311 | $26 |
| Losartan | 21 | $304 | $14 |
| Hydrochlorothiazide | 30 | $285 | $10 |
| Lorazepam | 21 | $253 | $12 |
| Montelukast | 18 | $230 | $13 |
| Triamcinolone Acetonide | 18 | $229 | $13 |
| Trazodone | 16 | $224 | $14 |
| Omeprazole | 24 | $200 | $8 |
| Simvastatin | 15 | $183 | $12 |
| Metoprolol | 15 | $177 | $12 |
| Clotrimazole | 12 | $158 | $13 |
| Sulfamethoxazole-Trimethoprim | 39 | $136 | $3 |
| Amlodipine Besylate | 20 | $128 | $6 |
| Alprazolam | 29 | $125 | $4 |
| Tramadol | 15 | $115 | $8 |
| Amoxicillin-Clavulanate Potass | 13 | $112 | $9 |
| Furosemide | 16 | $111 | $7 |
| Ciprofloxacin | 20 | $98 | $5 |
| Zolpidem | 14 | $91 | $6 |
| Doxycycline Hyclate | 11 | $69 | $6 |
| Diazepam | 15 | $59 | $4 |
2020: 3 drugs
| Nitrofurantoin Mono-Macro | 27 | $420 | $16 |
| Lisinopril | 11 | $124 | $11 |
| Sulfamethoxazole-Trimethoprim | 19 | $66 | $3 |
Money from drug and device companies
$630 in 2025
| 2025 | 5 | 10 | None | $630 |
| 2024 | 10 | 76 | None | $1,880 |
| 2023 | 13 | 86 | None | $1,940 |
| 2022 | 16 | 132 | None | $2,315 |
| 2021 | 23 | 125 | None | $2,676 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Yeztugo | $158 | 4 payments
|
| Janssen Biotech | Tremfya | $140 | 1 payment
|
| ViiV Healthcare | Apretude | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $125 | 1 payment
|
| Abbvie | Qulipta | $81 | 3 payments
|
See all 10 published payments
| Gilead Sciences | Meals · 2025-11-24 | None | $25 |
| Abbvie | Meals · 2025-09-30 | Ubrelvy | $32 |
| ViiV Healthcare | Meals · 2025-08-20 | Apretude | $125 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-14 | None | $125 |
| Gilead Sciences | Meals · 2025-08-14 | None | $12 |
| Gilead Sciences | Meals · 2025-08-07 | Yeztugo | $93 |
| Gilead Sciences | Meals · 2025-07-23 | None | $29 |
| Janssen Biotech | Meals · 2025-07-21 | Tremfya | $140 |
| Abbvie | Meals · 2025-03-19 | Qulipta | $16 |
| Abbvie | Meals · 2025-01-18 | Qulipta | $34 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,880
| Abbvie | Qulipta | $641 | 24 payments
|
| Pfizer | Nurtec Odt | $255 | 13 payments
|
| Lilly USA | Mounjaro | $237 | 7 payments
|
| Novo Nordisk | Rybelsus | $165 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $145 | 6 payments
|
| Astellas Pharma US | Veozah | $114 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $104 | 4 payments
|
| Amgen | Otezla | $101 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $64 | 3 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $53 | 2 payments
|
2023: $1,940
| Abbvie | Qulipta | $699 | 31 payments
|
| Novo Nordisk | Rybelsus | $280 | 13 payments
|
| Astellas Pharma US | Veozah | $208 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $143 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $130 | 6 payments
|
| Lilly USA | Mounjaro | $105 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $97 | 6 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $92 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $54 | 3 payments
|
| Pfizer | Nurtec Odt | $53 | 3 payments
|
| Amgen | Otezla | $44 | 2 payments
|
| Radius Health | Tymlos | $24 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $11 | 1 payment
|
2022: $2,315
| Abbvie | Vraylar | $367 | 21 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $344 | 23 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $332 | 12 payments
|
| Novo Nordisk | Rybelsus | $292 | 19 payments
|
| Lilly USA | Emgality | $265 | 15 payments
|
| Janssen Pharmaceuticals | Xarelto | $128 | 5 payments
|
| Amgen | Evenity | $127 | 17 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $127 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $94 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $75 | 4 payments
|
| Merck Sharp & Dohme | Belsomra | $56 | 3 payments
|
| Bausch Health US | Aplenzin | $39 | 2 payments
|
| Eisai | Dayvigo | $21 | 1 payment
|
| Radius Health | Tymlos | $17 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $16 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
2021: $2,676
| Novo Nordisk | Ozempic | $632 | 31 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $316 | 15 payments
|
| AbbVie | Ubrelvy | $263 | 11 payments
|
| Astellas Pharma US | Myrbetriq | $169 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $164 | 3 payments
|
| Lilly USA | Emgality | $159 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $149 | 9 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $114 | 5 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $97 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $96 | 5 payments
|
| Eisai | Dayvigo | $95 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $75 | 3 payments
|
| Teva Pharmaceuticals USA | Ajovy | $55 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $55 | 3 payments
|
| Amarin Pharma | Vascepa | $48 | 2 payments
|
| Amgen | Evenity | $45 | 3 payments
|
| Novartis Pharmaceuticals | Aimovig | $37 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $22 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $21 | 1 payment
|
| Sunovion Pharmaceuticals | Aptiom | $18 | 1 payment
|
| Radius Health | Tymlos | $16 | 1 payment
|
| TherapeuticsMD | Annovera | $15 | 1 payment
|
| Pfizer | Cologuard Dna Capture Reagents | $12 | 1 payment
|
Professional record
- NPI
- 1902455272
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1 Embarcadero Ctr Ste 1900, San Francisco, CA, 94111
- NPI first listed
- 2019-09-09
- NPI last updated
- 2025-10-02
- NPI record certified
- 2025-10-02
This is when the NPI record was last certified, not a medical board exam.